Floatz logo

Aralast Np

Chronic Obstructive Pulmonary Disease

ShirePhase 4 / ApprovedDormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

22 Active assets in the Chronic Obstructive Pulmonary Disease cohort.

Asset / SponsorPhaseRating
Liraglutide
Claus Bogh Juhl
Phase 4BB
Roflumilast
Prince of Songkla University
Phase 3BB
Ciprofloxacin
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase 4BB
Tazobactam
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase 4BB
Piperacillin
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase 4BB

View all 50 →

Same molecule, other indications

Aralast Np is also rated in:

alpha 1-antitrypsin deficiencyDormant
CC
Indicative ·
47 / 100
View asset →
type 1 diabetes mellitusDormant
CC
Indicative ·
40 / 100
View asset →
diabetes mellitusDormant
C
Indicative ·
32 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →